CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.

CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now. On June 5, Wells Fargo ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...

CVS Health (NYSE:CVS) snapped seven straight sessions of gains as the stock closed 0.92% lower, at $67.09 on Tuesday. The ...

Shares of CVS Health Corp. CVS rose 1.67% to $67.46 Friday, on what proved to be an all-around poor trading session for the ...

Investing.com -- CVS Health (NYSE: CVS) stock rose 1% on Wednesday after Bloomberg reported that Medicare Pharmacy Benefit Manager (PBM) limits were stripped from the Senate version of the tax bill.

Elevance Health reported a benefit expense ratio of 86.4% in the first quarter, up 80 bps year over year, mainly because Medicaid rates failed to keep up with medical cost trends. High-cost trends ...

Healthcare reform will likely remain a recurring political topic until universal, affordable coverage is achieved in the US, and CVS' stock may experience volatility if scenarios that threaten its ...